Close Menu

Harvard's Pardis Sabeti -- researcher, role model, and rock star -- is profiled in this issue of Science. Sabeti has quickly become visible in her field because of a knack for hard work, raising money, and reaching out to the community, as well as being a pretty good singer. Currently, she is working on uncovering evidence of selection in the human genome in relation to susceptibility to Lassa fever.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.